World Media

China vaccine’s low efficacy due to high-risk group, says Sinovac CEO

Share
A medical officer is injected with a Covid-19 vaccine by a nurse at RSUD hospital in Bogor on Jan 14 2021

Still, the varying results have raised questions about the true efficacy rate of the Chinese vaccine.Sinovac and the Chinese government have expressed full confidence in their vaccine, pointing to the use of the vaccine among the country's diplomatic corps.

Indonesia's almost 1.5 million medical workers will be among the first to be immunized after it became the first country outside China to start mass vaccinations with Sinovac's CoronaVac vaccine.

"No country receives their entire order in one shot", he said.

President Erdogan will receive his second dose of vaccine after 28 days.

She also wrote, "In the long term, many vaccines against Covid are needed to vaccinate the world and, inevitably, some will perform better than others - but giving as many people as possible some protection is the priority". He added, "In this system, we could see whether a health worker had COVID-19 and whether they could be vaccinated depending on their health condition".

Indonesia, the world's fourth most populous country, plans to vaccinate two-thirds of its population of about 270 million people - or just over 180 million people.

But Andreas Harsono, Indonesia researcher for Human Rights Watch, warned a "private vaccination programme will create the risk that the poorest and most vulnerable in the outer islands will be trampled in the stampede for vaccines".

"Prime Minister has already stated that India's vaccine production and delivery capacity would be used for the benefit of all humanity in fighting this crisis", Mr. Srivastava said.

'There are some people doing negative campaigning (about vaccinations) but I am sure common sense will prevail, ' Erdogan said as a masked doctor stabbed him with a needle while a nurse put a comforting arm on his shoulder.

The Sinovac vaccine underwent studies in Turkey, Brazil and Indonesia, and there's uncertainty over just how protective it is.

The rollout comes as Indonesia registered the daily record in COVID-19 infections and fatalities on Wednesday, with 11,278 cases and 306 deaths in the last 24 hours.

Besides Indonesia, the Sinovac vaccine has been granted conditional use authorization in China and Bolivia. Turkey ranks seventh globally in recorded cases at 2.35 million and 18th in virus-linked deaths, which are now over 23,000.

The Malaysian company Pharmaniaga Bhd signed a deal Tuesday with Sinovac to buy 14 million doses of CoronaVac and later to manufacture the vaccine locally.

"We are a small country but we will easily overcome this", Pilli said.

"The number of vaccines in the first stage is clear".

Supakit Sirilak, chief of the Department of Medical Sciences, yesterday insisted the government was still likely to proceed with its order of two million doses, starting next month. China has several vaccines in development.

Share